CSR CKD Stages and Dietary Management 1 — Questions and Answers

Question 1: According to KDIGO 2012, CKD Stage 3 is further divided into 3a and 3b based on GFR thresholds. What GFR range defines Stage 3b?

GFR 45–59 mL/min/1.73m²
GFR 30–44 mL/min/1.73m² (Correct answer)
GFR 15–29 mL/min/1.73m²
GFR 60–89 mL/min/1.73m²

Correct answer: GFR 30–44 mL/min/1.73m²

CKD Stage 3b is defined by GFR 30–44 mL/min/1.73m², representing moderately to severely decreased kidney function. Stage 3a covers GFR 45–59 mL/min/1.73m² (moderately decreased).

KDIGO 2012 staging: G1 ≥90, G2 60–89, G3a 45–59, G3b 30–44, G4 15–29, G5 <15 mL/min/1.73m². The 3a/3b subdivision carries prognostic significance: Stage 3b has higher rates of CKD progression, cardiovascular events, and hospitalizations than 3a. Dietary interventions typically intensify in Stage 3b: protein restriction initiated (0.6–0.8 g/kg/day), sodium limited to <2.3 g/day, phosphorus monitoring begins, potassium may need restriction if hyperkalemia emerges, and bicarbonate supplementation started if serum HCO3 <22 mEq/L. Referral to renal dietitian is recommended by KDOQI at GFR <45 mL/min/1.73m².

Question 2: In early CKD (Stage 1–2), the dietary intervention with the STRONGEST evidence for preserving kidney function in patients with diabetic nephropathy is:

Strict potassium restriction to <1000 mg/day
Sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy combined with blood glucose control and dietary sodium restriction (Correct answer)
High-dose vitamin C supplementation to reduce glomerular oxidative stress
Elimination of all animal protein from the diet

Correct answer: Sodium-glucose cotransporter-2 (SGLT2) inhibitor therapy combined with blood glucose control and dietary sodium restriction

In diabetic nephropathy, optimal glycemic control (HbA1c <7%), SGLT2 inhibitors (renoprotective effect via hemodynamic and metabolic mechanisms), and sodium restriction form the evidence-based cornerstone of early CKD management.

SGLT2 inhibitors (empagliflozin, canagliflozin, dapagliflozin) reduce intraglomerular pressure via tubuloglomerular feedback (reducing afferent arteriolar tone), decrease hyperfiltration, and lower albuminuria — demonstrating 30–40% reduction in CKD progression and ESRD in large RCTs (CREDENCE, DAPA-CKD, EMPA-KIDNEY). Dietary sodium restriction (< 2.3 g/day) reduces proteinuria and blood pressure. Glycemic control (HbA1c 7–8% in advanced CKD to avoid hypoglycemia risk) slows mesangial expansion and glomerular basement membrane thickening. Protein restriction in early diabetic CKD is less strongly supported than in non-diabetic CKD and should avoid excess protein (>1.3 g/kg/day) while maintaining adequate intake (0.8 g/kg/day).

Question 3: For a CKD Stage 4 patient (GFR 20 mL/min) with hyperphosphatemia, when should phosphate binders be taken to maximize efficacy?

Taken on an empty stomach 1 hour before meals
Taken during or immediately after meals containing phosphorus (Correct answer)
Taken at bedtime for overnight phosphorus control
Taken once daily in the morning regardless of meals

Correct answer: Taken during or immediately after meals containing phosphorus

Phosphate binders must be taken with meals containing dietary phosphorus because they work by binding phosphate in the GI tract before absorption. Timing with food maximizes the binding of dietary phosphate.

Phosphate binders (calcium carbonate, calcium acetate, sevelamer carbonate, lanthanum carbonate, sucroferric oxyhydroxide, ferric citrate) are effective only when taken with phosphorus-containing meals/snacks. The binder must physically contact dietary phosphate in the GI lumen. If taken fasted, the binder passes through without effect and may cause constipation or hypercalcemia (for calcium-based binders) without benefit. Dietitians play a key role in educating patients to match binder dose to phosphorus content of each meal/snack. High-phosphorus meals require more binders; low-phosphorus meals or pure carbohydrate snacks may not require binders. Non-adherence to phosphate binders is a major cause of treatment failure in hyperphosphatemia.

Question 4: A CKD Stage 3 patient on an ACE inhibitor develops serum potassium of 5.8 mEq/L. Which dietary approach is the FIRST-LINE recommendation?

Restrict dietary potassium to <1000 mg/day immediately
Implement a moderate potassium restriction of 2000–2500 mg/day with leaching techniques for high-potassium vegetables (Correct answer)
Switch the patient to a high-protein diet to promote cellular potassium uptake
Prescribe sodium polystyrene sulfonate without any dietary change

Correct answer: Implement a moderate potassium restriction of 2000–2500 mg/day with leaching techniques for high-potassium vegetables

Moderate potassium restriction (2000–2500 mg/day) combined with food preparation techniques (leaching/boiling vegetables) is the appropriate first dietary step for mild-moderate hyperkalemia in CKD, rather than overly restrictive limits that may impair diet quality.

Potassium management in CKD requires individualization based on serum levels, medication effects, and dietary assessment. For K+ 5.5–6.0 mEq/L: moderate dietary restriction to 2000–3000 mg/day is typically recommended. Leaching techniques for vegetables (peeling, cutting small, soaking in water 2+ hours, boiling in large volume of water and discarding water) can reduce vegetable potassium content by 30–60%. Low-potassium substitutions should maintain dietary quality. Recent KDIGO guidelines acknowledge that overly strict potassium restriction may inadvertently reduce fiber, base-producing foods, and plant-based protein intake — potentially accelerating CKD progression. Serum K+ ≥ 6.5 mEq/L requires urgent medical management including potassium binders, dialysis consideration, and ECG monitoring.

Question 5: The 'KDIGO heat map' used for CKD staging considers two variables to predict CKD progression risk and prognosis. What are these two variables?

Serum creatinine level and patient age
GFR category (G1–G5) and albuminuria category (A1–A3) (Correct answer)
Blood pressure and serum phosphorus
Body weight and dietary protein intake

Correct answer: GFR category (G1–G5) and albuminuria category (A1–A3)

The KDIGO CKD prognosis table (heat map) uses GFR categories (G1–G5) on one axis and albuminuria categories (A1: <30 mg/g, A2: 30–300 mg/g, A3: >300 mg/g) on the other, with color coding (green/yellow/orange/red) indicating risk of CKD progression.

KDIGO 2012 introduced a two-dimensional CKD staging/prognosis system: GFR categories (G1 ≥90, G2 60–89, G3a 45–59, G3b 30–44, G4 15–29, G5 <15) and albuminuria categories (A1 <30 mg/g normal-mildly increased, A2 30–300 mg/g moderately increased, A3 >300 mg/g severely increased). The heat map color-codes risk from green (low risk) through yellow (moderately increased), orange (high), to red (very high risk) for CKD progression, all-cause mortality, and cardiovascular events. Importantly, a patient can be Stage G2A3 with higher risk than G3aA1. Albuminuria independently predicts outcomes, making its measurement essential in CKD monitoring and in guiding dietary protein, sodium, and blood pressure interventions.

Question 6: Which of the following foods is MOST appropriate as a protein source for a CKD Stage 4 patient trying to maintain adequate intake while minimizing phosphorus load?

Processed cheese (2 oz)
Egg whites (3 large) (Correct answer)
Dark chicken meat with bone (3 oz)
Whole milk (8 oz)

Correct answer: Egg whites (3 large)

Egg whites provide high biological value protein (all essential amino acids) with virtually no phosphorus (egg yolk contains phosphorus), making them ideal for CKD patients who need protein without phosphorus burden.

Egg whites are one of the best protein sources in renal dietetics: each large egg white provides ~3.6 g protein, 0 mg phosphorus, 54 mg sodium, and 54 mg potassium. The egg yolk contains nearly all the egg's phosphorus (~95 mg/yolk), cholesterol, and fat. Three egg whites provide ~11 g HBV protein with negligible phosphorus. Comparison of phosphorus-to-protein ratios: processed cheese ~130–200 mg P per 7 g protein; whole milk ~220 mg P per 8 g protein per cup; dark chicken meat ~190 mg P per 3 oz; egg whites ~1–2 mg P per serving. Dietitians commonly use egg whites as a 'gold standard' protein-to-phosphorus comparison. Also useful: egg white protein powder (low P, high protein) for patients with poor appetite.

CSR CKD Stages and Dietary Management 1

According to KDIGO 2012, CKD Stage 3 is further divided into 3a and 3b based on GFR thresholds.
What GFR range defines Stage 3b?